BIK and MCL1

  • Number of citations of the paper that reports this interaction (PMID 16697956)
  • 236
  • Data Source:
  • HPRD (in vitro)

BIK

MCL1

Gene Name BCL2-interacting killer (apoptosis-inducing) myeloid cell leukemia 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 11 interactors: APP BCL2 BCL2A1 BCL2L1 BCL2L2 CRKL FATE1 MCL1 NR2F2 SOCS3 TANK 29 interactors: BAD BAK1 BAX BBC3 BCL2L1 BCL2L11 BID BIK BMF BOK CASP3 DAD1 FBXW7 GSK3A GSK3B HRK HUWE1 MAPK1 MAPK10 PCNA PIN1 PMAIP1 TNKS TP53 TPT1 TRAF6 UHRF2 USP9X VDAC1
Entrez ID 638 4170
HPRD ID 04547 08870
Ensembl ID ENSG00000100290 ENSG00000143384
Uniprot IDs Q13323 C8YZ26 Q07820
PDB IDs 2IPE 2KBW 2NL9 2NLA 2PQK 3D7V 3IO9 3KJ0 3KJ1 3KJ2 3KZ0 3MK8 3PK1 3TWU 4HW2 4HW3 4HW4
Enriched GO Terms of Interacting Partners?
Tagcloud ?
abt  actinomycin  antagonism  antagonizing  bak  bcl  bh3  carfilzomib  concurrent  crc  cyclohexamide  ectopic  ectopically  enabled  irreversible  isogenic  kras  mimetic  noxa  overcome  potently  sensitized  sequestered  shrna  synergistic  synergistically  synergy  ultimately  xl 
34a  bcl6  bim  btk  buffering  dlbcl  doi  fluctuations  follicular  foxp1  gab1  immunoglobulins  intimately  leu  lymphocytic  mantle  marginal  mirnas  modulators  myb  niches  preview  pu  put  stochastic  subtle  summarizing  tcl1  zap 
Tagcloud (Difference) ?
abt  actinomycin  antagonism  antagonizing  bak  bcl  bh3  carfilzomib  concurrent  crc  cyclohexamide  ectopic  ectopically  enabled  irreversible  isogenic  kras  mimetic  noxa  overcome  potently  sensitized  sequestered  shrna  synergistic  synergistically  synergy  ultimately  xl 
34a  bcl6  bim  btk  buffering  dlbcl  doi  fluctuations  follicular  foxp1  gab1  immunoglobulins  intimately  leu  lymphocytic  mantle  marginal  mirnas  modulators  myb  niches  preview  pu  put  stochastic  subtle  summarizing  tcl1  zap 
Tagcloud (Intersection) ?